India Health Fund (IHF) and the Tata Institute for Genetics and Society (TIGS) have formalized a Memorandum of Understanding (MoU) to collaborate on advancing science-led, technology-driven solutions to major communicable and non- communicable health challenges.

The partnership brings together IHF’s catalytic innovation platform and TIGS’s world class research expertise to support development of technologies that can fast track India’s trajectory towards alleviation of its public health challenges.

Under the MoU, IHF and TIGS will jointly work on initiatives across a range of critical areas, including areas of collaboration:

• Support translation of proof-of-concept stage innovations within climate- sensitive infectious diseases, One Health Antimicrobial Resistance (AMR) and other allied areas
• Co-develop innovative solutions, conduct joint research, feasibility assessments, and validation studies for promising health technologies
• Provide mentorship to start-ups on validation, quality management, evidence generation, regulatory processes and compliance mechanisms
• Facilitate knowledge exchange, technical expertise, and stakeholder engagement
  
  

This MoU is poised to catalyze breakthroughs that improve the health and well-being of communities across India.

Signing this strategic MoU, Mr. Madhav Joshi, CEO, IHF says,

“This partnership marks a powerful convergence of scientific excellence and innovation-driven public health action. Together with TIGS, we aim to develop and accelerate solutions that can meaningfully improve health outcomes across India.”

Echoing this sentiment, Dr. Rakesh Mishra, Director, TIGS says,

“Collaboration with India Health Fund marks a significant step towards accelerating science-based solutions for infectious diseases, improve access to affordable and quality diagnostics and fostering health equity. We also foresee this unique opportunity towards co-developing innovations for public health delivery”.

About IHF:

India Health Fund (IHF), a not-for-profit organization, aims to advance societal progress towards the elimination of infectious diseases and other public health risks with a particular focus on improving access to healthcare, equity, and preventing mortality. Since its founding in 2017 by the Tata Trusts, IHF has been at the forefront in generating a catalytic effect on the financing of India’s progress to meet the evolving landscape of public health challenges. IHF funds the development and de- risking of science and technology-based innovations along with supporting evidence- generation to bolster their lab-to-last-mile journey. IHF also builds partnerships and collaborations to strengthen health systems and improve health equity with scalable and sustainable approaches.

About TIGS:

The Tata Institute for Genetics and Society (TIGS), founded in 2017, is a non-profit research institute that aspires to develop solutions to challenges in human health and agriculture. The most significant challenges that impede the achievement of health equity and nutrition security for all of India’s population require systematic evidence-based scientific advancements and technological solutions. In this regard, we are committed to contributing towards India’s accelerated path in emerging as a global power through concerted efforts that use science-based solutions to prevent infectious diseases, improve access to affordable and quality diagnostics and therapeutics for rare genetic disorders, foster health equity, and achieve nutrition security through sustainable models for agriculture.